An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients

BioMedical Engineering OnLine

Shanshan Tang¹  Yiyi Zhuge¹ 

[1] Department of Gynecology, Hangzhou Women’s Hospital, No. 369 Kunpeng Road, Shangcheng District, 310008, Hangzhou, Zhejiang, China;

关键词: Uterine corpus endometrial cancer;    Immune;    Pseudogene;    Survival;    Signature;   

DOI  :  10.1186/s12938-021-00902-7

来源: Springer

【 摘 要 】

BackgroundPseudogenes show multiple functions in various cancer types, and immunotherapy is a promising cancer treatment. Therefore, this study aims to identify immune-related pseudogene signature in endometrial cancer (EC).MethodsGene transcriptome data of EC tissues and corresponding clinical information were downloaded from The Cancer Genome Atlas (TCGA) through UCSC Xena browser. Spearman correlation analysis was performed to identify immune-related pseudogenes (IRPs) between the immune genes and pseudogenes. Univariate Cox regression, LASSO, and multivariate were performed to develop a risk score signature to investigate the different overall survival (OS) between high- and low-risk groups. The prognostic significance of the signature was assessed by the Kaplan–Meier curve, time-dependent receiver operating characteristic (ROC) curve. The abundance of 22 immune cell subtypes of EC patients was evaluated using CIBERSORT.ResultsNine IRPs were used to build a prognostic signature. Survival analysis revealed that patients in the low-risk group presented longer OS than those in the high-risk group as well as in multiple subgroups. The signature risk score was independent of other clinical covariates and was associated with several clinicopathological variables. The prognostic signature reflected infiltration by multiple types of immune cells and revealed the immunotherapy response of patients with anti-programmed death-1 (PD-1) and anti-programmed cell death 1 ligand 1 (PD-L1) therapy. Function enrichment analysis revealed that the nine IRPs were mainly involved in multiple cancer-related pathways.ConclusionWe identified an immune-related pseudogene signature that was strongly correlated with the prognosis and immune response to EC. The signature might have important implications for improving the clinical survival of EC patients and provide new strategies for cancer treatment.

【 授权许可】

CC BY